Everence Capital Management’s Boston Scientific BSX Stock Holding History

Everence Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.17M	Hold	50,500	–	–	0.19%	101
2025 Q4	$4.82M	Hold	50,500	–	–	0.29%	56
2025 Q3	$4.93M	Hold	50,500	–	–	0.3%	55
2025 Q2	$5.42M	Hold	50,500	–	–	0.35%	44
2025 Q1	$5.09M	Buy	50,500 +840	+2%	+$84.6K	0.35%	46
2024 Q4	$4.44M	Buy	49,660 +6,770	+16%	+$596K	0.29%	54
2024 Q3	$3.59M	Hold	42,890	–	–	0.23%	80
2024 Q2	$3.08K	Hold	42,890	–	–	0.21%	88
2024 Q1	$2.94K	Hold	42,890	–	–	0.19%	99
2023 Q4	$2.48M	Buy	42,890 +1,680	+4%	+$89.7K	0.18%	108
2023 Q3	$2.18K	Hold	41,210	–	–	0.17%	113
2023 Q2	$2.12M	Hold	41,210	–	–	0.17%	112
2023 Q1	$2.06K	Hold	41,210	–	–	0.17%	115
2022 Q4	$1.91K	Buy	41,210 +12,030	+41%	+$521K	0.16%	116
2022 Q3	$1.13M	Hold	29,180	–	–	0.1%	170
2022 Q2	$1.09M	Hold	29,180	–	–	0.1%	175
2022 Q1	$1.29M	Sell	29,180 -8,920	-23%	-$387K	0.1%	169
2021 Q4	$1.62M	Hold	38,100	–	–	0.12%	152
2021 Q3	$1.65M	Hold	38,100	–	–	0.14%	133
2021 Q2	$1.63M	Hold	38,100	–	–	0.13%	131
2021 Q1	$1.47M	Hold	38,100	–	–	0.13%	133
2020 Q4	$1.37M	Buy	38,100 +6,043	+19%	+$218K	0.13%	130
2020 Q3	$1.23M	Hold	32,057	–	–	0.13%	131
2020 Q2	$1.22M	Hold	32,057	–	–	0.14%	122
2020 Q1	$1.05M	Hold	32,057	–	–	0.15%	122
2019 Q4	$1.45M	Sell	32,057 -3,275	-9%	-$137K	0.22%	99
2019 Q3	$1.44M	Hold	35,332	–	–	0.23%	97
2019 Q2	$1.52M	Hold	35,332	–	–	0.25%	91
2019 Q1	$1.36M	Buy	35,332 +7,140	+25%	+$273K	0.24%	99
2018 Q4	$996K	Hold	28,192	–	–	0.23%	111
2018 Q3	$1.08M	Hold	28,192	–	–	0.22%	122
2018 Q2	$922K	Hold	28,192	–	–	0.19%	141
2018 Q1	$770K	Hold	28,192	–	–	0.17%	154
2017 Q4	$699K	Hold	28,192	–	–	0.15%	170
2017 Q3	$822K	Hold	28,192	–	–	0.19%	149
2017 Q2	$781K	Hold	28,192	–	–	0.19%	147
2017 Q1	$701K	Hold	28,192	–	–	0.18%	153
2016 Q4	$610K	Sell	28,192 -9,526	-25%	-$208K	0.18%	166
2016 Q3	$898K	Hold	37,718	–	–	0.27%	109
2016 Q2	$881K	Sell	37,718 -8,280	-18%	-$179K	0.27%	108
2016 Q1	$865K	Buy	45,998 +16,250	+55%	+$285K	0.27%	120
2015 Q4	$549K	Buy	29,748 +10,642	+56%	+$191K	0.18%	159
2015 Q3	$314K	Hold	19,106	–	–	0.11%	225
2015 Q2	$338K	Hold	19,106	–	–	0.11%	220
2015 Q1	$323K	Hold	19,106	–	–	0.11%	226
2014 Q4	$253K	Sell	19,106 -13,020	-41%	-$166K	0.09%	246
2014 Q3	$407K	Hold	32,126	–	–	0.15%	181
2014 Q2	$410K	Hold	32,126	–	–	0.15%	189
2014 Q1	$434K	Hold	32,126	–	–	0.17%	176
2013 Q4	$386K	Buy	+32,126	New	+$380K	0.16%	183

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Everence Capital Management's BSX Position: Q1 2026 in Review

Everence Capital Management held its Boston Scientific (BSX) position steady in Q1 2026 at 50,500 shares worth $3.17M. The position accounts for 0.19% of the portfolio, ranked #101.

Everence Capital Management first reported a position in BSX in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.42M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Everence Capital Management held 50,500 shares of Boston Scientific worth $3.17M as of Q1 2026.
Everence Capital Management left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.19% of Everence Capital Management's portfolio in Q1 2026, its #101 holding.
Everence Capital Management first reported a position in Boston Scientific in Q4 2013 and has held it in 50 quarters since.
Everence Capital Management's Boston Scientific position peaked at $5.42M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.